HENRY SCHEIN SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Henry Schein, Inc. - HSIC
NEW ORLEANS, April 6, 2018 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 7, 2018 to file lead plaintiff applications in a securities class action lawsuit against Henry Schein, Inc. (NasdaqGS: HSIC), if they purchased the Company's securities between March 7, 2013 and February 12, 2018, inclusive (the "Class Period"). This action is pending in the United States District Court for the Eastern District of New York.
Get Help
Henry Schein investors should visit us at https://www.claimsfiler.com/cases/view-henry-schein-inc-securities-litigation or call to speak to our claim center toll-free at (844) 367-9658.
About the Lawsuit
Henry Schein and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On February 12, 2018, the Federal Trade Commission ("FTC") disclosed that it had filed a complaint against the Company for violating antitrust regulations through a conspiracy with other dental supply companies agreeing to refuse to offer discounts or service to buying groups representing dental practitioners.
On this news, the price of Henry Schein's shares plummeted $4.79 per share, or over 6.6%.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.
SOURCE ClaimsFiler
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article